PGA Tour hits Trey Mullinax with six-month doping ban

The PGA Tour doesn't hand out doping suspensions often, which is exactly why this one landed like a gut punch. Trey Mullinax, a Tour winner with one career title to his name, was suspended 6 months for violating the Tour's anti-doping policy after testing positive for a substance prohibited by the World Anti-Doping Agency.

Fore Play

@ForePlayPod

PGA Tour winner Trey Mullinax has been suspended 6 months for violating the Tour’s anti-doping policy.

Per the PGA Tour's own announcement, Mullinax isn't eligible to tee it up again until January 16, 2027 — basically wiping out the rest of this season and a chunk of next. That makes him the 9th player suspended since the Tour started drug testing back in 2008, and the first since Byeong Hun An got popped in October 2023 for a cough syrup mix-up. Small club, and not one anybody wants membership in.

Both sides put out statements, and they read less like a scandal and more like a guy owning a dumb mistake. Mullinax says he used a medication to treat a condition he was originally diagnosed with back in college, and never ran it by the Tour's anti-doping program first. That's the violation — not some grand PED scheme, just a failure to check a box.

Fore Play

@ForePlayPod

Statements from the PGA Tour & Trey Mullinax ⤵️

"My lack of knowledge is not an excuse," Mullinax said in his statement. "It was my responsibility to know the rules before taking any medication and I failed to do so. I want to be absolutely clear: I have never taken any substance with the intention of gaining a competitive advantage." He added that he takes full responsibility and that golf has given him too much to not own up to it.

For context on the stakes here: Mullinax's one Tour win came at the Barbasol Championship, where he beat Kevin Streelman by a shot and punched a ticket into that year's Open at St Andrews. It's not a Hall of Fame résumé, but it's a livelihood, and a 6-month ban is a real chunk of both a season and a paycheck for a guy who isn't winning majors and cashing appearance fees.

The bigger question this raises is how the Tour's anti-doping program handles cases that clearly aren't about gaining an edge. There's no accusation here that Mullinax was chasing extra distance or recovery — just a guy who took medicine for a legitimate condition without clearing it first. Doesn't matter under WADA's strict-liability rules, but it's a reminder that these policies don't care about intent, only whether the paperwork got filed.